Patients receiving Kyprolis should be aware of the risk of infusion reactions and other serious adverse effects. It is important to inform the healthcare provider of any pre-existing conditions like heart disease or kidney dysfunction. Patients should also report any unusual symptoms immediately, such as chest pain or difficulty breathing. Regular monitoring, including blood tests and heart function assessments, is often necessary during treatment.
